IMNM•benzinga•
LifeSci Capital Initiates Coverage On Immunome with Outperform Rating, Announces Price Target of $20
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 11, 2025 by benzinga